Mirostipen

N/A

Report date: 2024/01/10 15:13:55

Base Information

Drug NameMirostipen
Drug Alias NameHG-00300HGO-0300
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionC-C chemokine receptor type 1 modulators
TargetsC-C chemokine receptor type 1
Therapy Area/IndicationsChemotherapy-induced myelosuppression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHuman Genome Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHuman Genome Sciences IncTakeda Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsChemotherapy-induced myelosuppression

Other Information

ATC CodeN/A
Related LinksN/A